MMR DEFICIENCY

Clinical trials for MMR DEFICIENCY explained in plain language.

Never miss a new study

Get alerted when new MMR DEFICIENCY trials appear

Sign up with your email to follow new studies for MMR DEFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Radioactive 'Smart Bomb' targets tough cancers in early trial

Disease control Recruiting now

This early-phase study tests a new drug called 177Lu-RAD204, which is a radioactive antibody that seeks out and attaches to a protein (PD-L1) on cancer cells. The goal is to see if it is safe and tolerable for people with advanced solid tumors like lung, breast, or skin cancer th…

Matched conditions: MMR DEFICIENCY

Phase: EARLY_PHASE1 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control

Last updated May 14, 2026 12:06 UTC

MMR DEFICIENCY

Get alerted when new MMR DEFICIENCY trials appear

Radioactive 'Smart Bomb' targets tough cancers in early trial